award

Phase 2 Study of Avacopan for Treatment of C3G, IND 132321, Orphan Designation 16-5590

  • Award Number: R01FD006342

  • ORGANIZATION: FOOD AND DRUG ADMINISTRATION

  • OPDIV: FDA

  • AWARD CLASS: DISCRETIONARY

  • AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

  • PERIOD OF PERFORMANCE START DATE: 09/10/2019

  • PERIOD OF PERFORMANCE END DATE: 01/31/2022